Von Hippel-Lindau disease masquerading as autosomal dominant polycystic kidney disease

被引:18
|
作者
Chatha, RK
Johnson, AM
Rothberg, PG
Townsend, RR
Neumann, HPH
Gabow, PA
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Med, PKD Res C283, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Radiol, Denver, CO 80262 USA
[3] Denver Hlth, Denver, CO USA
[4] Childrens Mercy Hosp, Kansas City, MO 64108 USA
[5] Univ Freiburg, Med Klin, Dept Nephrol, D-7800 Freiburg, Germany
关键词
autosomal dominant polycystic kidney disease (ADPKD); von Hippel-Lindau (VHL) disease; pancreatic cysts; pancreatic malignancy; misdiagnosis;
D O I
10.1016/S0272-6386(01)80136-0
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The diagnostic confusion in differentiating the various causes of renal cystic diseases in adults is well documented. This confusion can include misclassifications between autosomal dominant polycystic kidney disease (ADPKD) and von Hippel-Lindau disease (VHL). We describe such a case of VHL. A review of the literature and of the patients in our database regarding typical features of each disease, mean age of onset, and frequency of these features was undertaken to provide helpful differentiating features. Pancreatic cysts are one differentiating feature. In VHL, pancreatic cysts can occur in 70% of patients, often are multiple, and rarely may cause exocrine or endocrine Insufficiency. Pancreatic islet cell tumors occur. In ADPKD, pancreatic cysts are found in only 9% of patients, usually are single and asymptomatic, generally occur in conjunction with cystic liver disease, and are not found in children or unaffected family members. Pancreatic malignancies do not occur with increased frequency In ADPKD. A different pattern, especially in patients without a strong family history of ADPKD, may be a clue to VHL masquerading as ADPKD. Genetic mutation screening of the VHL gene should be used in these patients. (C) 2001 by the National Kidney Foundation, Inc.
引用
收藏
页码:852 / 858
页数:7
相关论文
共 50 条
  • [41] Safety study of somatostatin analogue octreotide for autosomal dominant polycystic kidney disease in Japan
    Eiji Higashihara
    Kikuo Nutahara
    Takatsugu Okegawa
    Mitsuhiro Tanbo
    Hideaki Mori
    Isao Miyazaki
    Toshiaki Nitatori
    Kuninori Kobayashi
    Clinical and Experimental Nephrology, 2015, 19 : 746 - 752
  • [42] Rapid head growth in a baby with autosomal dominant polycystic kidney disease (ADPKD): Questions
    Shute, Rachel
    Jeelani, Owase
    Lee, Lucy
    Brennan, Eileen
    Bockenhauer, Detlef
    Barnicoat, Angela
    Shroff, Rukshana
    PEDIATRIC NEPHROLOGY, 2014, 29 (02) : 217 - 218
  • [43] Evidence of retinal arteriolar narrowing in patients with autosomal-dominant polycystic kidney disease
    Pietrzak-Nowacka, Maria
    Lejkowska, Renata
    Kawa, Milosz Piotr
    Ulanczyk, Zofia
    Safranow, Krzysztof
    Nowacka, Barbara
    Podboraczynska-Jodko, Karolina
    Lubinski, Wojciech
    Ciechanowski, Kazimierz
    Machalinski, Boguslaw
    Machalinska, Anna
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2022, 76 (01): : 174 - 176
  • [44] Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease
    Yao, Qing
    Wu, Ming
    Zhou, Jie
    Zhou, Meiyang
    Chen, Dongping
    Fu, Lili
    Bian, Rongrong
    Xing, Xiaohong
    Sun, Lijun
    Hu, Xiaohong
    Li, Lin
    Dai, Bing
    Wuthrich, Rudolf P.
    Ma, Yiyi
    Mei, Changlin
    KIDNEY & BLOOD PRESSURE RESEARCH, 2017, 42 (01) : 156 - 164
  • [45] Pancreatic Cysts and Intraductal Papillary Mucinous Neoplasm in Autosomal Dominant Polycystic Kidney Disease
    McNicholas, Bairbre A.
    Kotaro, Yoshida
    Martin, William
    Sharma, Ayush
    Kamath, Patrick S.
    Edwards, Marie E.
    Kremers, Walter K.
    Chari, Suresh T.
    Torres, Vicente E.
    Harris, Peter C.
    Takahashi, Naoki
    Hogan, Marie C.
    PANCREAS, 2019, 48 (05) : 698 - 705
  • [46] Rapid head growth in a baby with autosomal dominant polycystic kidney disease (ADPKD): Questions
    Rachel Shute
    Owase Jeelani
    Lucy Lee
    Eileen Brennan
    Detlef Bockenhauer
    Angela Barnicoat
    Rukshana Shroff
    Pediatric Nephrology, 2014, 29 : 217 - 218
  • [47] Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease
    Grampsas, SA
    Chandhoke, PS
    Fan, J
    Glass, MA
    Townsend, R
    Johnson, AM
    Gabow, P
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (01) : 53 - 57
  • [48] Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal disease
    Sharp, CK
    Zeligman, BE
    Johnson, AM
    Duley, I
    Gabow, PA
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (05) : 863 - 868
  • [49] Expression and secretion of CXCL12 are enhanced in autosomal dominant polycystic kidney disease
    Kim, Hyunho
    Sung, Jinmo
    Kim, Hyunsuk
    Ryu, Hyunjin
    Park, Hayne Cho
    Oh, Yun Kyu
    Lee, Hyun-Seob
    Oh, Kook-Hwan
    Ahn, Curie
    BMB REPORTS, 2019, 52 (07) : 463 - 468
  • [50] Zebrafish Model as a Screen to Prevent Cyst Inflation in Autosomal Dominant Polycystic Kidney Disease
    Oliveira, Ines
    Jacinto, Raquel
    Pestana, Sara
    Nolasco, Fernando
    Calado, Joaquim
    Lopes, Susana Santos
    Roxo-Rosa, Monica
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)